Emergent BioSolutions (EBS) Shares Outstanding (Diluted) (2010 - 2026)
Emergent BioSolutions (EBS) posted Shares Outstanding (Diluted) of 51.6 million for Q2 2026, down 4.8% from 54.2 million a year earlier and down 8.7% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2025, Emergent BioSolutions' Shares Outstanding (Diluted) came in at 56.7 million, up 7.0% from FY2024.
- Annual Shares Outstanding (Diluted) has increased for three consecutive years, with a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Shares Outstanding (Diluted) was 53 million in FY2024 (+3.5%), 51.2 million in FY2023 (+2.2%), 50.1 million in FY2022 (-7.4%) and 54.1 million in FY2021 (+0.6%).
- The Q2 2026 figure stands as the lowest quarterly Shares Outstanding (Diluted) since Q4 2023.
- On a year-over-year basis, Shares Outstanding (Diluted) increased in six of the last eight quarters, with growth averaging 3.3%.
- The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q1 2025, with growth of 9.8%; the weakest was Q2 2022, with a decline of 7.4%.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 56.5 million (Q1 2026), 56.7 million (Q4 2025) and 56.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.39 Bn | 1,131.97 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 634.39 Bn | 552.91 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 502.68 Bn | 475.79 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 377.37 Bn | 331.74 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 266.55 Bn | 240.24 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 240.56 Bn | 195.96 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 193.19 Bn | 167.38 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Emergent BioSolutions | 318.37 Mn | -432.53 Mn | 137.20 Mn | 51.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.60 Mn |
| Mar 31, 2026 | 56.50 Mn |
| Dec 31, 2025 | 56.70 Mn |
| Sep 30, 2025 | 56.50 Mn |
| Jun 30, 2025 | 54.20 Mn |
| Mar 31, 2025 | 57.30 Mn |
| Dec 31, 2024 | 53.00 Mn |
| Sep 30, 2024 | 55.60 Mn |
| Jun 30, 2024 | 52.60 Mn |
| Mar 31, 2024 | 52.20 Mn |
| Dec 31, 2023 | 51.20 Mn |
| Sep 30, 2023 | 51.80 Mn |
| Jun 30, 2023 | 50.70 Mn |
| Mar 31, 2023 | 50.20 Mn |
| Dec 31, 2022 | 50.10 Mn |
| Sep 30, 2022 | 49.90 Mn |
| Jun 30, 2022 | 50.00 Mn |
| Mar 31, 2022 | 50.70 Mn |
| Dec 31, 2021 | 54.10 Mn |
| Sep 30, 2021 | 53.70 Mn |
API Access
Emergent BioSolutions Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();